Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and safety of heterologous and homologous prime-boost schedules with adenoviral vectored and inactivated COVID-19 vaccines
TCTR20210913001Completed
- Sponsor
- Royal College of Physicians of Thailand
- Start
- Sep 2021
- Countries
- 1
01
Overview
Trial of Covidful in coronavirus disease 2019 (COVID-19), sponsored by Royal College of Physicians of Thailand. Started Sep 2021; status: completed.
02
Drugs
Covidful
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210913001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210913001.